Home > Result Summaries: Compounds > Dutasteride > Result Summary for ARI105326

Result Summary for ARI105326

Result Summary
Protocol ID: ARI105326
Clinical Study ID: ARI105326
Official Title: Clinical Evaluation of GI198745 in Benign Prostatic Hyperplasia- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparative Study of GI198745 in Patients with Benign Prostatic Hyperplasia
Phase: phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Tsukamoto T, Endo Y, Narita M; Efficacy and safety of dutasteride in Japanese men with benign prostatatic hyperplasia. Int J Urol. 2009 Sep.16(9).745-50